Overview

Levetiracetam Treatment of Neonatal Seizures

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Current treatments for the brain damaging complication of neonatal seizures are unsatisfactory. A multi-centre Chinese clinical trials with the aim to using oral Levetiracetam to develop new treatment strategies for the treatment of neonatal seizures. The purpose of this study is to determine the correct oral dosing, safety and efficacy for oral Levetiracetam as first line treatment in term new born babies with seizures.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Children's Hospital of Fudan University
Collaborators:
Guangzhou Women and Children's Medical Center
Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Maternal and Child Health Hospital of Hubei Province
Second Affiliated Hospital of Wenzhou Medical University
The Maternal & Children Health Hospital of Dehong, Yunnan of China
Xiamen Children's Hospital, Fujian of China
Treatments:
Etiracetam
Levetiracetam
Phenobarbital
Piracetam